172 related articles for article (PubMed ID: 31704599)
21. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.
Valpione S; Gremel G; Mundra P; Middlehurst P; Galvani E; Girotti MR; Lee RJ; Garner G; Dhomen N; Lorigan PC; Marais R
Eur J Cancer; 2018 Jan; 88():1-9. PubMed ID: 29175734
[TBL] [Abstract][Full Text] [Related]
22. Relevance of serum biomarkers associated with melanoma during follow-up of anti-CTLA-4 immunotherapy.
Felix J; Cassinat B; Porcher R; Schlageter MH; Maubec E; Pages C; Baroudjian B; Homyrda L; Boukouaci W; Tamouza R; Bagot M; Caignard A; Toubert A; Lebbé C; Moins-Teisserenc H
Int Immunopharmacol; 2016 Nov; 40():466-473. PubMed ID: 27728898
[TBL] [Abstract][Full Text] [Related]
23. Clinical use of p-proteasome in discriminating metastatic melanoma patients: comparative study with LDH, MIA and S100B protein.
Henry L; Fabre C; Guiraud I; Bastide S; Fabbro-Peray P; Martinez J; Lavabre-Bertrand T; Meunier L; Stoebner PE
Int J Cancer; 2013 Jul; 133(1):142-8. PubMed ID: 23238767
[TBL] [Abstract][Full Text] [Related]
24. CT texture analysis of pancreatic cancer.
Sandrasegaran K; Lin Y; Asare-Sawiri M; Taiyini T; Tann M
Eur Radiol; 2019 Mar; 29(3):1067-1073. PubMed ID: 30116961
[TBL] [Abstract][Full Text] [Related]
25. Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.
Weide B; Martens A; Hassel JC; Berking C; Postow MA; Bisschop K; Simeone E; Mangana J; Schilling B; Di Giacomo AM; Brenner N; Kähler K; Heinzerling L; Gutzmer R; Bender A; Gebhardt C; Romano E; Meier F; Martus P; Maio M; Blank C; Schadendorf D; Dummer R; Ascierto PA; Hospers G; Garbe C; Wolchok JD
Clin Cancer Res; 2016 Nov; 22(22):5487-5496. PubMed ID: 27185375
[TBL] [Abstract][Full Text] [Related]
26. Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
Woff E; Hendlisz A; Ameye L; Garcia C; Kamoun T; Guiot T; Paesmans M; Flamen P
J Nucl Med; 2019 Feb; 60(2):178-184. PubMed ID: 29959212
[TBL] [Abstract][Full Text] [Related]
27. FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy.
Flaus A; Habouzit V; De Leiris N; Vuillez JP; Leccia MT; Perrot JL; Prevot N; Cachin F
Sci Rep; 2021 Sep; 11(1):18795. PubMed ID: 34552135
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular Carcinoma: Texture Analysis of Preoperative Computed Tomography Images Can Provide Markers of Tumor Grade and Disease-Free Survival.
Oh J; Lee JM; Park J; Joo I; Yoon JH; Lee DH; Ganeshan B; Han JK
Korean J Radiol; 2019 Apr; 20(4):569-579. PubMed ID: 30887739
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
30. Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach.
Guerrisi A; Russillo M; Loi E; Ganeshan B; Ungania S; Desiderio F; Bruzzaniti V; Falcone I; Renna D; Ferraresi V; Caterino M; Solivetti FM; Cognetti F; Morrone A
Front Oncol; 2021; 11():704607. PubMed ID: 34692481
[TBL] [Abstract][Full Text] [Related]
31. Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy.
Gabani P; Robinson CG; Ansstas G; Johanns TM; Huang J
Radiother Oncol; 2018 May; 127(2):310-317. PubMed ID: 29534829
[TBL] [Abstract][Full Text] [Related]
32. CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib.
Haider MA; Vosough A; Khalvati F; Kiss A; Ganeshan B; Bjarnason GA
Cancer Imaging; 2017 Jan; 17(1):4. PubMed ID: 28114978
[TBL] [Abstract][Full Text] [Related]
33. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
34. Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma.
Hamberg AP; Korse CM; Bonfrer JM; de Gast GC
Melanoma Res; 2003 Feb; 13(1):45-9. PubMed ID: 12569284
[TBL] [Abstract][Full Text] [Related]
35. Peri-SRS Administration of Immune Checkpoint Therapy for Melanoma Metastatic to the Brain: Investigating Efficacy and the Effects of Relative Treatment Timing on Lesion Response.
Yusuf MB; Amsbaugh MJ; Burton E; Chesney J; Woo S
World Neurosurg; 2017 Apr; 100():632-640.e4. PubMed ID: 28179176
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
[TBL] [Abstract][Full Text] [Related]
37. Macroangiopathy is a positive predictive factor for response to immunotherapy.
Deike-Hofmann K; Gutzweiler L; Reuter J; Paech D; Hassel JC; Sedlaczek O; Radbruch A; Schlemmer HP; Bäumer P
Sci Rep; 2019 Jul; 9(1):9728. PubMed ID: 31278360
[TBL] [Abstract][Full Text] [Related]
38. Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?
Pandey A; Pandey P; Ghasabeh MA; Zarghampour M; Khoshpouri P; Ameli S; Luo Y; Kamel IR
Radiology; 2018 Dec; 289(3):843-853. PubMed ID: 30129899
[TBL] [Abstract][Full Text] [Related]
39. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
40. Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab.
Khene ZE; Kokorian R; Mathieu R; Gasmi A; Nathalie RL; Solène-Florence KJ; Shariat S; de Crevoisier R; Laguerre B; Bensalah K
Int J Clin Oncol; 2021 Nov; 26(11):2087-2093. PubMed ID: 34338919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]